Please read and agree to the terms and conditions of this site.
@xconomy.com 4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com 5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@techcrunch.com 7 years ago
Regenerative medicine today is like the internet in 1993